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Abstract Genome amplification (DNA synthesis) is one of
the most demanding cellular processes in all proliferative
cells. The DNA replication machinery (also known as the
replisome) orchestrates genome amplification during S-
phase of the cell cycle. Genetic material is particularly vulner-
able to various events that can challenge the replisome during
its assembly, activation (firing), progression (elongation) and
disassembly from chromatin (termination). Any disturbance
of the replisome leads to stalling of the DNA replication fork
and firing of dormant replication origins, a process known as
DNA replication stress. DNA replication stress is considered
to be one of the main causes of sporadic cancers and other
pathologies related to tissue degeneration and ageing. The
mechanisms of replisome assembly and elongation during
DNA synthesis are well understood. However, once DNA
synthesis is complete, the process of replisome disassembly,
and its removal from chromatin, remains unclear. In recent
years, a growing body of evidence has alluded to a central role
in replisome regulation for the ubiquitin-dependent protein
segregase p97, also known as valosin-containing protein
(VCP) in metazoans and Cdc48 in lower eukaryotes. By or-
chestrating the spatiotemporal turnover of the replisome, p97
plays an essential role in DNA replication. In this review, we
will summarise our current knowledge about how p97 con-
trols the replisome from replication initiation, to elongation
and finally termination.We will also further examine the more
recent findings concerning the role of p97 and how mutations
in p97 cofactors, also known as adaptors, cause DNA replica-
tion stress induced genomic instability that leads to cancer and
accelerated ageing. To our knowledge, this is the first compre-
hensive review concerning the mechanisms involved in the
regulation of DNA replication by p97.
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Introduction
Duplication of the genomic information (DNA) is a key ob-
jective for any dividing cell. All nuclear DNA has to be du-
plicated in an accurate way during S-phase of the cell cycle to
ensure that the genetic information stays preserved for the next
generation (Masai et al. 2010; Toueille and Hubscher 2004).
In human cells, DNA replication has to accurately copy
around 6 × 109 bases over approximately 10 h during S-
phase (Goren and Cedar 2003); therefore, it must be spatio-
temporally regulated at different levels. Any disturbance of
this process might introduce mutations and chromosomal ab-
errations that could lead to various diseases such as stem cell
depletion, neurodegeneration, cancer and accelerated
(premature) ageing (Brambati et al. 2015; Fragkos et al.
2015; Macheret and Halazonetis 2015). The initiation of
DNA replication starts at multiple origins of replication along
chromosomes. Here, a pre-replicative complex (Pre-RC) is
formed in a process known as licensing (Heller et al. 2011).
Licensing begins at the end of mitosis and early G1-phase of
the cell cycle with the loading of the main component of the
replicative helicase: the hexameric minichromosome mainte-
nance 2–7 (Mcm) complex. Loading of the Mcm2-7 complex,
and therefore origin licensing, requires the six subunit origin
recognition complex (ORC1-6), cell division cycle 6 (Cdc6)
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and chromatin licensing and DNA replication factor 1 (Cdt1)
(Mehanna and Diffley 2012; Nishitani and Lygerou 2002;
Yardimci and Walter 2014). Licensing is complete when
ORC1-6 and Cdc6 convert individual heptamers of Mcm2-
7-Cdt1 into head-to-head double hexamers ofMcm2-7 around
double-stranded DNA, with the subsequent release of Cdt1
and Cdc6 (Yekezare et al. 2013). Subsequently, origin activa-
tion (firing) starts in S-phase of the cell cycle with the activa-
tion ofMcm2-7. The main firing factors, cell division cycle 45
(Cdc45) and the GINS (for Go, Ichi, Nii and San: five, one,
two and three in Japanese) complex, associate with Mcm2-7
and form a functional CMG (Cdc45,Mcm2-7, GINS) helicase
that powers the progression of the replication fork. The asso-
ciation of Cdc45 and GINS with Mcm2-7 depends on addi-
tional firing factors such as DNA Topoisomerase 2-binding
protein (TopBP1), the TopBP1 binding protein Treslin and
the DNA replication regulators Sld2 and Dpb11 (Boos et al.
2012; Heller et al. 2011). Activation of the pre-RC, and sub-
sequent origin firing, is largely regulated by the CDK (cyclin-
dependent kinase) and DDK (Dbf4-dependent kinase) ki-
nases, but also an additional factor, Mcm10, whose binding
to the Mcm2-7 complex is essential for the recruitment of the
single-stranded DNA binding protein replication protein A
(RPA), resulting in the initiation of DNA replication (Yeeles
et al. 2015). Origin firing occurs at random locations
and different timing throughout S-phase, classified as early
and late origin firing, and proceeds in a bi-directional manner
along the DNA. Once an origin has fired, the CMG helicase
complex starts to unwind the double-stranded DNA ahead of
the replication fork. This is then followed by the core DNA
replication machinery [PCNA (proliferating cell nuclear anti-
gen), the DNA polymerases α, δ and ε, RPA and Fen1 (Flap
endonuclease 1), amongst others] which carries out synthesis
of the new ‘daughter’ DNA strand (Barlow and Nussenzweig
2014; Fragkos et al. 2015; Yeeles et al. 2015). High topolog-
ical stress ahead of the DNA replication fork, produced during
DNA unwinding by the CMG helicase complex, is released
by a specialised group of enzymes called topoisomerases.
Topoisomerases cleave, untwist and re-ligate single- or
double-strandedDNA ahead of the DNA replication fork, thus
releasing topological stress to ensure undisturbed DNA syn-
thesis (Chen et al. 2013). When an ongoing DNA replication
fork from one origin meets an incoming DNA replication fork
from an adjacent origin, DNA replication is stopped and
disassembled in a process called termination (Bailey et al.
2015; Dewar et al. 2015). It is worth mentioning that licensing
occurs only once per cell cycle, and that all the potential ori-
gins are licensed at the beginning of S-phase. On the contrary,
only a handful of the origins that are licensed are actually
utilised to complete replication. Most licensed origins remain
dormant (dormant origins) during ongoing replication and are
passively replicated by forks arising from neighbouring ori-
gins (Alver et al. 2014).
Besides the spatiotemporal orchestration of replication li-
censing, firing, initiation and termination, various additional
obstacles constantly challenge the progression of a replication
fork. This can include a variety of DNA lesions, DNA sec-
ondary structures, tightly bound DNA–protein complexes,
collisions with transcription machinery, an inefficient pool of
dNTPs, or unscheduled oncogene-activated firing of DNA
replication (Gaillard et al. 2015; Petermann and Helleday
2010). Each of these challenges may affect the stability of
the DNA replication fork. The inability of the replisome to
cope with any of those challenges causes DNA replication
stress and potentially error-prone DNA synthesis (Macheret
and Halazonetis 2015). DNA replication stress is
characterised by several parameters: (i) the velocity of repli-
cation fork is severely reduced, (ii) increase of fork stalling,
(iii) firing of dormant origins, (iv) increased amounts of long
stretches of single stranded DNA coated by RPA, (v) activa-
tion of the ataxia telangiectasia-mutated and Rad3-related
(ATR)/Checkpoint kinase 1 (CHK1) signalling pathway and
consequently the intra-S-phase checkpoint, (vi) formation of
DNA double-strand breaks due to nucelolytic attack of long
stretches of unprotected DNA and consequently activation of
the ataxia telangiectasia-mutated (ATM)/Checkpoint kinase 2
(CHK2) signalling pathway, (vii) increased DNA end resec-
tion, (viii) increased levels of ultrafine chromosomal bridges
and finally (ix) elevated levels of p53-binding protein 1
(53BP1) bodies in G1-phase of the cell cycle. Together, these
hallmarks of DNA replication stress are considered to be one
of the main sources of genomic instability that can ultimately
lead to ageing-related phenotypes such as cancer (Da-Re and
Halazonetis 2015; Macheret and Halazonetis 2015), stem cell
depletion, tissue degeneration and even neurodegeneration
(Burhans and Weinberger 2007; Yurov et al. 2011).
Phosphorylation events, mostly controlled by CDK and
DDK kinases, are known to play a major role in the coordi-
nation of the DNA replication fork (Sclafani and Holzen
2007).
However, in the last decade, other posttranslational modi-
fications, such as ubiquitination and SUMOylation, have
emerged as being equally as important, but their role and
function in the regulation of DNA replication are poorly un-
derstood (Bergink and Jentsch 2009; Moreno and Gambus
2015; Ulrich 2014). The molecular segregase p97 also known
as valsoin-containing protein (VCP) in metazoan or Cdc48 in
lower eukaryotes is a central molecule in the regulation of
ubiquitinated substrates and thus plays an essential role in
protein homeostasis. There is a growing amount of evidence
that ubiquitin-dependent regulation of the DNA replication
machinery by p97 is essential for faithful DNA synthesis
and genome stability (Vaz et al. 2013). In this review, we will
focus on the role of p97 in regulating the DNA replication
machinery. The ultimate goal of this review is to inform the
scientific community about the essential and necessary
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functions of the ubiquitin-dependent segregase p97 in coordi-
nating DNA replication.
Ubiquitin-dependent molecular segregase
p97 (VCP or Cdc48)
p97, also known as VCP in metazoans, CDC-48 in
Caenorhabditis elegans, Cdc48 in yeast and Ter94 in insects,
is an ubiquitin-dependent unfoldase/segregase that plays a
central role in the ubiquitin-proteasome system (UPS) and in
the regulation of protein homeostasis (Meyer et al. 2012;
Richly et al. 2005). For the sake of simplicity, we will use
the following abbreviations when specifically referring to
p97 in metazoans (p97/VCP), in yeast (p97/Cdc48) or in
worms (p97/CDC-48); otherwise, p97 will be used for general
statements. p97 recognises substrates via their ubiquitin mod-
ifications and subsequently transfers them either to the protea-
some for degradation or facilitates substrate recycling.
Similarly to ubiquitin and the proteasome, the p97 system
(p97 together with its cofactors, see below) is involved in a
variety of cellular processes (Meyer et al. 2012; Meyer and
Weihl 2014) (Fig. 1). The specificity of p97 toward diverse
substrates, cellular locations and pathways is coordinated by a
plethora of adaptor proteins, also known as p97 cofactors
(Buchberger et al. 2015; Yeung et al. 2008). There are about
30 known p97 cofactors that in various combinations form
numerous p97-subcomplexes, which are then directed to-
wards specific substrates and pathways (Meyer et al. 2012;
Meyer and Weihl 2014). All of the p97 cofactors are
characterised by p97 interacting motifs, and the majority of
them bind the N-terminal part of p97 (Yeung et al. 2008).
However, we still do not know exactly how many different
p97-subcomplexes exist or the specificity of different cofactor
combinations. Regardless of the cofactor composition, p97,
via its cofactors, predominantly binds ubiquitinated substrates
(Fig. 2) (Alexandru et al. 2008; Ye 2006). Once bound to a
substrate, p97 hydrolyses ATP, via the ATPase cassette in its
D2 domain, and utilises the released energy to undergo a con-
formational change across its homohexamer structure, also
referred to as an interprotomer motion transmission mecha-
nism (Huang et al. 2012; Li et al. 2012). This ATP-driven
interprotomer motion enables p97 to translocate substrates
through its narrow central pore (Tonddast-Navaei and Stan
2013), thus removing them from different cellular locations
such as the endoplasmic reticulum, chromatin, ribosomes or
protein-macro complexes. Consequently, unfolded and/or
segregated substrates are now easily recognised by the
Fig. 1 The role of p97 in various
cellular processes. The specificity
of p97 function towards
designated pathways and
substrates is coordinated by a
plethora of cofactors (depicted by
the arrows). ER endoplasmic
reticulum
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proteasome and are degraded or recycled with the help of p97-
associated deubiquitinating enzymes (see below). In addition
to its segregase and/or unfoldase activity, p97 also plays an
important role as a recruitment platform, although not neces-
sarily independently of the proteasome. This may serve as an
additional layer of substrate regulation involving
deubiquitinating enzymes, such as VCIP135 (valosin-contain-
ing interacting protein complex p97/p47 interacting-protein
135), Ataxin-3 and OTU1 (ovarian tumour domain-
containing protein 1) and E3-ubiquitin ligases, such as
AMFR (Autocrine Motility Factor Receptor)/gp78 and E4-
ubiquitin ligase Ufd2 (Ubiquitin fusion degradation protein
2) in yeast (UBE4A and UBE4B in mammals) (Hoppe
2005; Meyer and Weihl 2014). These aforementioned func-
tions are evolutionarily conserved and are essential for cell
survival. For instance, knockdown of both p97 alleles (p97
−/−) causes early-embryonic lethality in mice (Muller et al.
2007). Supporting this finding, siRNA-depletion of p97 in
cells causes apoptosis (Wojcik et al. 2004).
Since the discovery of p97 as cold-sensitive cell-division-
cycle mutant 48 (Cdc48) in yeast (Moir et al. 1982), VCP in
pigs (Koller and Brownstein 1987) and finally biochemically
and structurally characterised as the ring-like homohexameric
ATPase p97 (Peters et al. 1990), its known functions were
solely related to processes in the cytoplasm (Halawani and
Latterich 2006; Meyer 2005; Ye 2006) for more than two
decades. In 2007, it was discovered that p97/CDC-48 binds
and extracts polyubiquitinated protein kinase Aurora B from
chromatin during mitosis (Ramadan et al. 2007). Since this
discovery, chromatin-associated protein removal and degrada-
tion (CAD) has been emerging as an essential process in the
maintenance of genome stability (Beli and Jackson 2015;
Dantuma et al. 2014; Dantuma and Hoppe 2012; Moreno
and Gambus 2015; Ramadan 2012). It seems that p97 plays
a central role in CAD, and therefore, it has been recognised as
a genome caretaker (Vaz et al. 2013) (Fig. 3). p97, with the
help of its cofactors, recognises and remodels a diverse set of
chromatin-associated substrates. These are removed from
chromatin and, in the majority of cases, degraded by the pro-
teasome, or alternatively some of the substrates can also be
recycled (Acs et al. 2011; Bailey et al. 2015; Franz et al. 2011;
Meerang et al. 2011; Puumalainen et al. 2014; Ramadan 2012;
Ramadan et al. 2007). In relation to CAD, impairment of the
segregase or unfoldase activity of p97 causes the
hyperaccumulation of ubiquitinated proteins on chromatin. In
time, this interferes negatively with chromatin-related processes
such as mitosis, DNA replication, DNA repair and transcription
(Dantuma et al. 2014; Dantuma and Hoppe 2012; Vaz et al.
2013). Ultimately, the inhibition of CAD leads to protein-
induced chromatin stress (PICHROS) and, consequently, se-
vere DNA damage and genomic instability (Vaz et al. 2013).
This is best demonstrated in the case where p97 and its cofac-
tors Ufd1 (ubiquitin fusion degradation 1), Npl4 (nuclear pro-
tein localisation protein 4) and UBXD7 (UBX domain-
containing protein 7), the p97-Ufd1-Npl4-UBXD7 complex were
inhibited, resulting in the hyperaccumulation of the DNA dam-
age sensors DDB2 (damage specific DNA binding protein 2)
and XPC (Xeroderma pigmentosum, complementation group
C) at sites of UV-induced chromatin lesions (Puumalainen et al.
2014).
As the scope of this article concerns the role of p97 in DNA
replication, we will only discuss chromatin-associated protein
turnover at the site of DNA replication. To gain a deeper
understanding of the role of p97 in other CAD processes,
and how exactly p97 protects cells from PICHROS and ge-
nome instability, we suggest reading the following review
articles (Buchberger et al. 2015; Dantuma et al. 2014;
Dantuma and Hoppe 2012; Meyer et al. 2012; Meyer and
Weihl 2014; Vaz et al. 2013).
Multiple roles of p97 in DNA replication
p97 was shown to physically interact with DNA replication
associated proteins, such as the RecQ DNA helicase Werner
(Indig et al. 2004; Partridge et al. 2003) in human cells and
HIM-6 (Bloom helicases homolog) in C. elegans (Caruso
et al. 2008). The first evidence that p97 is required for DNA
replication emerged from the Hoppe laboratory (Mouysset
et al. 2008).
The Hoppe group has demonstrated in C. elegans the im-
portance of the p97/CDC-48 UFD-1 NPL-4 complex (p97/
CDC-48-UFD-1-NPL-4) for DNA replication in dividing cells
which are essential for embryonic cell division and germ line
development of adult worms. Depletion of any of the compo-
nents of the p97/CDC-48-UFD-1-NPL-4 complex in C. elegans
embryos leads to severe replication-related DNA stress. This
was manifested as: (i) increased levels of chromosomal aber-
rations such as chromosome bridges, (ii) decreased DNA con-
tent, (iii) increased amounts of stalled and collapsed DNA
Fig. 2 The ubiquitinated substrate is bound to a cofactor that contains a
ubiquitin-binding domain and is presented to p97. The substrate is shifted
into the central pore of p97 and remodelled by ATPase activity of p97.
This allows substrate unfolding and/or extraction from different cellular
compartments of protein-protein complexes
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replication forks visualised by Rad51 foci formation, (iv) de-
layed S-phase progression due to activation of the DNA
replication-related checkpoint ATR-CHK1 signalling cascade
and (v) hypersensitivity of embryos to hydroxyurea-induced
replication stress. Whilst co-depletion of ATR or CHK-1 in
p97/CDC-48-UFD-1-NPL-4 depleted cells restored S-phase pro-
gression, it was not able to rescue the formation of chromo-
somal bridges. This suggests that the role of p97/CDC-
48-UFD-1-NPL-4 is directly linked to DNA replication and
not to the DNA replication-related checkpoint signalling cas-
cade (Deichsel et al. 2009; Mouysset et al. 2008).
Interestingly, the authors concluded that worms depleted
for p97/CDC-48, UFD-1 and NPL-4 show a strong reduction
in DNA content, which resembles the loss of the DNA repli-
cation licensing factors Cdt1 and CDC6. However, the follow-
up work has further demonstrated that p97/CDC-48 together
with its cofactor Fas-associated 1 (FAF1) binds ubiquitinated
Cdt1 and facilitates its degradation (Franz et al. 2016).
Altogether, these data suggest that p97/CDC-48 regulates
and promotes Cdt1 degradation, and therefore, the inactiva-
tion of p97/CDC-48 should instead cause re-replication due to
high level of Cdt1 rather than a reduction in DNA content.
Why p97/CDC-48-depleted worm cells, despite the high level
of Cdt1, have less DNA content and whether p97/CDC-48
depleted cells show signs of re-replication still remains un-
clear and needs further study.
This initial work (Mouysset et al. 2008) highlighted the
role of p97 in DNA replication and also provided a platform
for further influential research in that direction. Indeed, recent
work from several laboratories has highlighted the complexity
of the p97 system in DNA replication (Fig. 4) (Davis et al.
2012; Franz et al. 2011, 2016; Ghosal et al. 2012; Maric et al.
2014; Moreno et al. 2014; Mosbech et al. 2012; Raman et al.
2011; Stingele et al. 2014). Taking into consideration the spa-
tiotemporal dynamics of the DNA replication machinery dur-
ing DNA synthesis and the capability of p97 to remodel a
broad range of substrates, it is very likely that p97, together
with its cofactors, is involved in the processing and remodel-
ling of other, as of yet undiscovered, substrates associated
with the DNA replication machinery.
Initiation of DNA replication
A critical step in the initiation of DNA replication is the re-
cruitment of the licensing factor Cdt1 during G1 phase to the
origin of replication by the ORC complex (Mehanna and
Diffley 2012). Cdt1 licenses origins by recruiting the CMG
helicase which unwinds DNA, thus allowing the progression
of DNA replication (Maiorano et al. 2000; Nishitani et al.
2000). Cdt1 must be inactivated during S-phase to prevent
re-licensing of origins with the CMG helicase and conse-
quently re-replicating an already replicated part of the DNA
(Blow and Dutta 2005). Cdt1 inactivation is orchestrated by
binding of the inhibitory protein Geminin and by
ubiquitination by two cullin-RING-based E3-ubiquitin ligases
(CRL): SCF-Skp2 and CRL4-DDB1-Cdt2. This ubiquitination re-
sults in Cdt1 proteasomal degradation (Hu et al. 2004; Kondo
et al. 2004; Nishitani et al. 2006; Wohlschlegel et al. 2000;
Zhong et al. 2003). Cdt1 proteasomal degradation has long
been recognised as an essential step in regulating re-
replication and in the maintenance of genome stability. This
has recently been expanded upon by new findings from two
independent laboratories who have demonstrated that Cdt1
Fig. 3 p97 in chromatin-
associated degradation (CAD).
p97, together with its cofactors
(Ufd1-Npl4 complex, UBXD7,
SPRTN and FAF1), binds and
processes the ubiquitinated
substrate (S) on chromatin. The
substrate (S) is then released from
chromatin and either degraded by
the proteasome or recycled
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degradation is regulated by the p97/VCP/Cdc-48-Ufd1-Npl4
complex, and that this mechanism is conserved from worms
to humans (Franz et al. 2011; Raman et al. 2011) (Fig. 4a). The
Harper lab has investigated the factors necessary for Cdt1
degradation by performing a genome-wide siRNA screen in
HeLa cells (Raman et al. 2011). This approach identified p97
and its cofactor Ufd1 (p97-ufd1), but not Npl4, as essential
factors for the proteasomal degradation of Cdt1.
Furthermore, they have also identified another PCNA-
dependent subs t ra te of the E3-ub iqui t in l igase
CRL4A-DDB1-Cdt2, the histone methyltransferase SET8, which
is also targeted for degradation during replication (Raman
et al. 2011). SET8 is essential for cell cycle progression and
its depletion leads to slow S-phase progression and extensive
DNA damage, most probably due to high levels of histone H4
methylation at lysine 20 (H4K20) and consequently high
chromatin condensation (Jorgensen et al. 2007). During S-
phase, SET8 is kept low by CRL4A-DDB1-Cdt2 ubiquitination
and p97-dependent degradation to maintain a chromatin struc-
ture that allows DNA replication progression (Jorgensen et al.
2011; Raman et al. 2011). By using a combination of mam-
malian and Xenopus cell-free extracts, the authors demonstrat-
ed that the p97/VCP-Ufd1-Npl4 complex binds and removes the
ubiquitinated form of Cdt1 from chromatin (Raman et al.
Fig. 4 The multiple roles of p97
in DNA replication. a Licencing
and firing of DNA replication
origins is controlled by the p97-
Ufd1-Npl4 dependent degradation
of Cdt1. b A speculative model:
The bidirectional progression of
the DNA replication fork is
controlled by p97/Cdc48-WSS1
and p97/VCP-SPRTN proteolytic
removal of DPCs in front of DNA
replication fork. c The switch
between replicative and TLS
DNA polymerases at sites of
stalled replication forks is
facilitated by p97-Ufd1-Npl4-SPRTN.
d The inactivation of FANCI and
FANCD2 by p97-SPRTN in the FA
pathway. e The disassembly of the
MCM complex (a core
component of CMG helicase) at
the end of DNA replication
(termination of the DNA
replication fork) by p97-
dependent extraction of
ubiquitinated MCM7 (in red)
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2011). Similar results were obtained by independent work
performed in the Hoppe lab (Franz et al. 2011). They have
systematically analysed the subcellular localisation and dy-
namics of several conserved replication factors by time lapse
microscopy inC. elegans. Whilst in wild-typeC. elegans cells
the CDC-45/GINS complex dissociates from chromatin after
S-phase, inactivation of p97/CDC-48, or its core cofactors
UFD-1 and NPL-4, leads to the persistent accumulation of
CDC-45 and the GINS subunit SLD-5 throughout the cell
cycle. However, inactivation of the p97/CDC-48-UFD-1-NPL-4
complex does not affect other replication factors such as
ORC-2, CDC-6 or MCM-2, suggesting a substrate-specific
role for p97 in DNA replication. In agreement with the previ-
ous results, P1 cell division delay in p97/CDC-48-depleted
C. elegans mitotic embryos could be restored by depletion
of either the licensing factor CDT-1 or the firing factors
CDC-45 and GINS, suggesting that the removal of the licens-
ing and firing factors is controlled by p97.
It was just recently demonstrated that another p97 cofactor,
Fas-associated factor 1 (FAF1), plays an essential role in the
stability of DNA replication forks in worms and several hu-
man cell lines (Franz et al. 2016). The p97-FAF1 complex, and
its worm homolog, CDC-48-UBXN-3, directly binds the
ubiquitinated licensing factor Cdt1, resulting in its removal
from chromatin and finally Cdt1 proteasomal degradation.
Inactivation of UBXN-3/FAF1 stabilises Cdt1 and Cdc45/
GINS on chromatin, causing severe defects in replication fork
dynamics (also see below) accompanied by an increased firing
of dormant origins, and activation of the DNA damage
checkpoint.
Elongation of DNA replication and DNA
replication-associated processes: translesion DNA
synthesis (TLS), the Fanconi anaemia (FA) pathway
and DNA-protein crosslink (DPC) repair
After firing of the DNA replication factories at various origins,
bidirectional and semiconservative DNA replication in eu-
karyotes allows the progression of the DNA replication fork
in both directions from the origin (Burhans et al. 1990;
Romero and Lee 2008). This process is called elongation of
DNA replication and continues until two opposite replication
forks converge. The DNA replication elongation process is
governed by the active replicative helicase CMG complex
which unwinds double stranded DNA, thus allowing unper-
turbed DNA synthesis (Moyer et al. 2006). Currently, there is
almost no evidence as to whether p97 or its cofactors play a
role in the elongation process of DNA replication (Fig. 4b).
However, monogenic and biallelic mutations in SPRTN
(Lessel et al. 2014), also known as DVC1, a recently identified
p97 cofactor (Davis et al. 2012; Ghosal et al. 2012; Mosbech
et al. 2012), or its depletion in various human cell lines, causes
severe DNA replication elongation defects, as measured by
the DNA fibre assays (Lessel et al. 2014). Patients with mu-
tated SPRTN (Lessel et al. 2014) also present a decrease in
replication fork velocity, which could be explained as an in-
direct consequence of dormant origin firing (Alver et al.
2014).
Also, another cofactor of p97, FAF1, as mentioned earlier
in the regulation of DNA initiation, also regulates DNA rep-
lication elongation (Franz et al. 2016). Depletion of FAF1 in
various human cell lines causes a severe reduction in DNA
replication fork velocity and an increased level of stalled forks
as measured by the DNA fibre assay. Decreased DNA fork
velocity and an increased level of stalled forks in FAF1 de-
pleted cells can be almost completely restored by co-depletion
of Cdt1. It is still not yet completely clear why co-depletion of
Cdt1 restores the fork progression in FAF1-depleted cells. It
could be as an indirect effect of increased loading of the
Mcm2-7 complex that is stimulated by elevated levels of
Cdt1. An increased level of Mcm2-7 might consequently
cause an increased level of dormant origin firing once cells
enter S-phase.
Translesion DNA synthesis Various obstacles such as
unrepaired DNA damage, DNA secondary structures, or
DNA-protein crosslinks (DPCs) constantly challenge the
DNA replication machinery during DNA elongation.
Similarly, various metabolic factors such as depletion of the
free dNTP pool also strongly threaten the progression of the
DNA replication fork (Mirkin and Mirkin 2007). An inability
of the DNA replication machinery to properly cope with all of
these obstacles causes DNA replication fork stalling, persis-
tence of which causes the stalled forks to collapse, leading to
the formation of potentially cytotoxic DNA double-strand
breaks. To prevent stalling and collapse of DNA replication
forks, cells have evolved specialised DNA polymerases that
are able to cope with various obstacles and bulky-DNA le-
sions in front of the DNA replication fork. This mechanism is
called translesion DNA synthesis (TLS) (Daigaku et al. 2010)
and is coordinated by ubiquitin and SUMO modifications on
PCNA (Chen et al. 2011; Plosky andWoodgate 2004). One of
the most common bulky-DNA lesions are thymidine dimers
induced by UV-light or other metabolic processes (Spivak and
Hanawalt 2015). Replicative DNA polymerases are unable to
incorporate nucleotides opposite these lesions, causing the
DNA replication machinery to stall and the replicative DNA
polymerase to be replacedwith a TLSDNA polymerase. After
the lesion has been bypassed by the TLS DNA polymerase(s),
the replicative DNA polymerases resume DNA synthesis. The
process of DNA polymerase exchange at sites of damage is
called DNA polymerase switching (Lehmann 2006).
Since the discovery of SPRTN, a body of evidence has
accumulated indicating that SPRTN, together with p97, regu-
lates DNA polymerase switching at sites of UV-induced DNA
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lesions (Davis et al. 2012; Ghosal et al. 2012; Kim et al. 2013;
Machida et al. 2012; Mosbech et al. 2012). SPRTN, through
its PCNA binding motif (PIP box) and ubiquitin binding do-
main (UBZ), is recruited to sites of stalled DNA replication
forks and regulates DNA polymerase switching (Fig. 4c). It
seems that SPRTN plays multiple roles during DNA polymer-
ases switching: (i) removing the replicative DNA polymerase
δ (Ghosal et al. 2012), (ii) facilitating DNA polymerase η
recruitment (Ghosal et al. 2012), (iii) removing DNA po-
lymerase η beyond the lesion (Davis et al. 2012; Mosbech
et al. 2012), (iv) regulating error-free TLS (Kim et al.
2013; Machida et al. 2012) and (v) enhancing the recruit-
ment of the E3 ligase Rad18 which monoubiquitinates
PCNA (Centore et al. 2012), an essential process for
TLS DNA polymerase recruitment. Furthermore, it was
also shown that SPRTN protects polyubiquitinated PCNA
from deubiquitination by antagonising USP1 protease ac-
tivity, thus promoting error-free TLS DNA damage bypass
at sites of stalled DNA replication forks and preventing
stalled forks from recombination (Juhasz et al. 2012). It is
well documented that SPRTN plays multiple roles at sites
of DNA replication. It seems that the ubiquitination status
of PCNA is monitored by the p97-SPRTN complex, which
can then further enhance the ubiquitination of PCNA,
governing either error-free TLS or the DNA damage
avoidance pathway (template switch) at sites of stalled
DNA replication forks (Kim et al. 2013; Machida et al.
2012). It was demonstrated that SPRTN, with its putative
metalloprotease active centre [glutamic acid at position
112 (E112) located in the SprT-domain], prevents DNA
damage induced mutagenesis at sites of stalled DNA rep-
lication forks. SPRTN prevents complex formation be-
tween DNA polymerase δ subunit 3 (POLD3), REV1
and DNA polymerase ζ that are involved in mutagenic
(error-prone) TLS. In this way, SPRTN stimulates error-
free TLS orchestrated by DNA polymerase η and extend-
ed by error-free DNA polymerases δ and ε.
SPRTN has many different domains (see Fig. 6 for domains
in SPRTN) that could direct its function towards specific sub-
strates, which might explain the diverse functions of SPRTN in
DNA replication. Once recruited to sites of stalled replication
forks in a PIP-box and UBZ-dependent manner, SPRTN re-
cruits the p97/VCP-Ufd1-Npl4 core complex via its SHP domain
to remove either DNA polymerase δ or η from sites of DNA
replication blocks (Davis et al. 2012; Ghosal et al. 2012;
Mosbech et al. 2012). Regardless of the precise molecular
insights into the function of SPRTN in TLS, it is very
likely that p97/VCP-Ufd1-Npl4, together with SPRTN (p97/
VCP-Ufd1-Npl4-SPRTN), is of major relevance for DNA replication
fork progression past replication-blocking damage, the mecha-
nism known as DNA damage tolerance (DDT). Further work is
necessary to understand how the p97-Ufd1-Npl4-SPRTN complex
controls DDT, as well as the substrates which it processes.
Fanconi anaemia pathway In addition to TLS synthesis, it
was also recently demonstrated that p97, together with
SPRTN, plays a role in the Fanconi anaemia (FA) DNA repair
pathway (Gibbs-Seymour et al. 2015) (Fig. 4d). FA is a rare
autosomal recessive disorder, in which at least 16 different
genes have so far been identified, relating to the FA pathway
(Longerich et al. 2014). Haematological abnormalities, due to
failure of the bone marrow, and cancer predisposition are the
main clinical characteristics of FA (Garaycoechea and Patel
2014). FA patient cells have increased levels of chromosomal
aberrations and are hypersensitive to DNA-interstrand
crosslinking (ICL) agents. ICLs represent a strong physical
barrier to moving DNA replication forks, causing fork stalling
and collapse. The FA pathway protein complex is recruited to
sites of ICLs and, with the action of its endonuclease activity,
cleaves DNA around the lesion, which then activates subse-
quent DNA repair pathways, such as HR (homologous recom-
bination), TLS or NER (nucleotide excision repair) (Crossan
and Patel 2012; Niedzwiedz et al. 2004). However, not only
ICL-inducing agents activate the FA pathway, but also many
other DNA replication stress-inducing agents such as hy-
droxyurea or aphidicolin. This suggests that the role of the
FA pathway is not ICLs specific but rather a DNA
replication-associated process (Jo and Kim 2015; Longerich
et al. 2014). FA pathway activation is potentially cytotoxic
due to its strong nuclease activity and, therefore, must be
tightly regulated. Regulation of the FA complex is under the
jurisdiction of various PTMs; it was recently demonstrated
that SUMOylation and ubiquitination play a role in FA-
dependent chromatin associated protein removal and degrada-
tion (Gibbs-Seymour et al. 2015; Kim and D’Andrea 2012).
Two components of the FA pathway, FANCI (FA, comple-
mentation group I) and FANCD2 (FA, complementation
group D2), are heavily SUMOylated and consequently
ubiquitinated by the SUMO-targeted E3-ubiquitin ligase
RNF4 (ring finger protein 4). The p97/VCP-SPRTN complex,
but not the three most abundant p97-cofactors Ufd1, Npl4 and
p47, recognises and extracts FANCI and FANCD2 from sites
of DNA damage (Gibbs-Seymour et al. 2015). Their extrac-
tion and removal by the p97/VCP-SPRTN complex strictly de-
pend on the segregase activity of p97, as a p97-segregase
defective mutant is not able to remove FANCI and FANCD2
from chromatin (Gibbs-Seymour et al. 2015). Based on the
abovementioned work, it is difficult to conclude whether p97/
VCP-SPRTN is the sole p97 complex that extracts and inacti-
vates the FA pathway complex, or whether other p97 cofactors
are involved in this process as well. Furthermore, although
these results suggest the importance of the p97-SPRTN complex
in the FA pathway, SPRTN-depleted cell show a very mild
sensitivity to MMC when compared to depletion of
FANCD2 (Gibbs-Seymour et al. 2015). Also, SPRTN-
mutated pat ients (Lessel et al . 2014) or SPRTN
haploinsuficiency mice (Maskey et al. 2014) (for details see
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below) do not have any haematological abnormalities which
would indicate an essential role for SPRTN in the FA pathway.
Therefore, the role of SPRTN in the FA pathway might
only be minor or represent a backup mechanism when other
components of the FA pathway are affected.
DNA-protein crosslink repair In yeast, the essential role of
the p97/Cdc48 system during the progression of DNA synthe-
sis and its function in coping with various obstacles in front of
the DNA replication fork was further strengthened by the
discovery of WSS1 and its role in the removal of covalently
bound Topoisomerase 1 (Top1) to DNA, known as Top1-cc
cleavage complex (Stingele et al. 2014). In addition, WSS1-
depleted yeast cells are hypersensitive to formaldehyde that
induces the covalent attachment of proteins to DNA, known
as DNA-protein crosslinks (DPCs). DPCs are highly muta-
genic and cytotoxic lesions, and if not removed from DNA,
these proteins present a severe block to the progression of the
DNA replication and RNA transcription machineries
(Tretyakova et al. 2013). Toxic DPCs arise from various prod-
ucts of metabolism such as formaldehyde and acetaldehyde or
by exogenous sources, such as UV-light. These sources (e.g.
aldehydes or UV-light) can potentially crosslink any protein in
the vicinity of DNA. Also, DPCs can arise from the enzymatic
action of proteins that form transient covalent interactions
with DNA like DNA polymerases, DNA methyltranferases
or topoisomerases. In general, the interaction between protein
and DNA is transient, but in some circumstances, the enzymes
can be trapped, thus causing the accumulation of DPCs
(Stingele and Jentsch 2015). Very little is known about how
DPCs are removed ahead of DNA replication forks, but also
how cells avoid DPC-induced cytotoxicity. Recent work from
two independent groups demonstrated that WSS1 is a DNA-
dependent metalloprotease important for the removal of cova-
lently trapped Top1-cc, an enzymatically induced DNA-
protein crosslink complex (DPCs) (Balakirev et al. 2015;
Stingele et al. 2014). Yeast lacking both WSS1 and tyrosyl-
DNA-phosphodiesterase (Tdp1; the enzyme that removes the
remaining fragment peptide on DNA after proteasome-
dependent degradation of Top1-cc) accumulate Top1-cc.
WSS1 cleaves Top1 but only in the presence of DNA, and
WSS1 proteolytic activity is inhibited by adding EDTA to the
react ion, suggest ing WSS1 is a DNA-dependent
metalloprotease. Further cellular characterisation of different
yeast mutants suggests that WSS1, in combination with p97/
Cdc48, is involved in the removal of toxic-DPCs during S-
phase DNA synthesis, but not bulky cellular DPCs. So, it
seems that p97/Cdc48-WSS1 plays a central role in the prote-
olysis of DNA-replication related DPCs and thus prevents
DNA replication fork stalling at sites of DPCs and conse-
quently DNA fork collapse (Fig. 4b), which would lead to
increased levels of recombination and genomic instability in-
duced by gross chromosomal rearrangements (Stingele et al.
2014). On top of the role of p97/Cdc48-WSS1 in proteolytic
removal of Top1-cc, it was also shown that p97/Cdc48-WSS1
and another p97 cofactor Doa1 form a novel p97 complex
(p97/Cdc48-Wss1-Doa1) that is recruited to SUMOylated sub-
strates on chromatin after DNA damage (Balakirev et al.
2015). Once recruited to chromatin, WSS1 possesses an in-
trinsic E3-SUMO ligase activity that further catalyses SUMO-
chain extension on chromatin substrates. This consequently
activates the WSS1 intrinsic protease activity that cleaves
and removes SUMOylated substrates from chromatin. So it
seems that the p97/Cdc48-WSS1-Doa1 complex with the intrin-
sic E3-SUMO ligase and proteolytic activities of WSS1 and
the segregase activity of p97 regulates the progression of
DNA replication when the DNA replication forks approaches
DNA-protein blocks that can either be DPCs or even non-
covalently, but tightly bound, proteins to DNA. It has also
been reported that the removal of DPCs is essential for the
progression of the DNA replication fork in Xenopus egg ex-
tract (Duxin et al. 2014). However, the enzyme(s) which
remove(s) DPCs in metazoans during DNA replication is/are
still not identified. SPRTN is a metazoan cofactor of p97/
Cdc48 with domain structure similar to that of WSS1
(Stingele et al. 2015). Both WSS1 and SPRTN contain N-
terminal protease (WSS1-protease in WSS1) or putative prote-
ase domain (SprT) and p97-interacting domain (SHP and VIM
in WSS1 and SHP in SPRTN). In contrast to SPRTN, which
contains two ubiquitin-binding domains and a PIP box impor-
tant for SPRTN recruitment to sites of stalled DNA replication
fork, WSS1 contains two SUMO-interacting motifs. Thus, it
would be interesting to investigate whether SPRTN is also a
protease which is important for the removal of DNA-protein
blocks in front of the DNA replication fork, andwhether similar
mechanisms for the removal of DPCs in front of DNA replica-
tion fork exist in metazoans and especially in mammals.
Termination of DNA replication
Termination of the DNA replication machinery occurs when
replication forks arising from two neighbouring origins meet
(Bailey et al. 2015; Dewar et al. 2015). In that moment, the
replisome, which is usually tightly bound to DNA, must be
disassembled. Although replisome loading and its activation
have been extensively studied, replisome termination was for
many years, somehow, neglected. Recently, independent work
from two laboratories demonstrated an essential role for p97
in replisome disassembly/termination (Fig. 4e) in yeast and
Xenopus laevis cell-free extracts, thus encircling another role
of p97 in DNA replication (Maric et al. 2014; Moreno et al.
2014). In budding yeast, the CMG helicase complex is
ubiquitinated in late S-phase, specifically on the MCM7 sub-
units, by the SCF-Dia2 ubiquitin ligase complex (Maric et al.
2014). This result suggested that ubiquitination of the CMG
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helicases occurs at the point of replisome termination.
Interestingly, disassembly of the CMG helicase complex at
the end of chromosomal replication strongly depends on the
segregase activity of p97/Cdc48, but not on the proteasome
(Maric et al. 2014; Moreno et al. 2014). p97/Cdc48 binds
SCF-Dia2 K48-ubiquitinated MCM7 and, using its ATPase
activity, removes the whole CMG complex. Inactivation of
p97/Cdc48, either by expressing temperature sensitive yeast
mutants or by removal of endogenous p97/Cdc48 using an
inducible degron system, leads to hyperaccumulation of chro-
matin bound CMG helicase with ubiquitinated MCM7, and
the retention of the whole CMG complex on chromatin until
the next G1 phase of the cell cycle (Maric et al. 2014). Similar
results were obtained biochemically in Xenopus egg extracts
(Moreno et al. 2014); inactivation of p97 function by comple-
mentation with a p97/VCPATPase inactive mutant led to the
accumulation of the ubiquitinated CMG complex on chroma-
tin. However, the eukaryotic E3-ubiqutin ligase which
ubiquitinates MCM7 at sites of DNA replication fork termi-
nation has not yet been identified. The work from both labs
(Maric et al. 2014; Moreno et al. 2014) clearly showed the
essential role of p97 in segregating the active replisome at the
end of replication by removing ubiquitinated MCM7 in a pro-
teasome independent manner. However, the p97 cofactors and
E3-ubiquitin ligase for ubiquitination of metazoan MCM7 for
replisome disassembly are still to be identified.
Disturbance of the p97 system in DNA replication
leads to cancer and premature ageing in humans
SPARTAN syndrome Direct evidence for the role of the p97
system in human diseases related to DNA replication defects
has just recently begun to emerge (Fig. 5). It has just been
discovered that biallelic and monogenic mutations in the p97
cofactor SPRTN causes a new human syndrome characterised
by chromosomal instability, early-onset hepatocellular carci-
noma and premature ageing (Lessel et al. 2014). The syn-
drome was officially named Ruijs-Aalfs Syndrome (RJALS)
according to the authors who described the first patient (family
A patient 1; A-1) as an atypical Werner Syndrome (Ruijs et al.
2003). Our discovery of the second family with two additional
patients (family B patients 2 and 3; B-2 and B-3), and whole
exome sequencing of all three patients confirmed this is a new
monogenic human syndrome caused by biallelic mutations in
the SPRTN gene (Fig. 6) (Lessel et al. 2014). As RJALS
syndrome is, amongst scientists, much better known as
SPARTAN (due to mutations in the SPRTN gene) syndrome
(Hiom 2014), we propose that both names could be used for
this syndrome.
All three patients, family A patient no. 1 (A-1) and family
B patients no. 2 and no. 3 (B-2 and B-3) developed hepato-
cellular carcinoma at the age of 13 years, two of which died of
Fig. 5 The role of replication related p97 functions in ageing and cancer
in humans. Mutations in the p97-adaptor SPRTN cause SPARTAN
syndrome characterised by premature ageing and early onset
hepatocellular carcinoma. p97 regulates Werner protein (WRN)
localisation, and mutations in WRN cause Werner Syndrome
characterised by premature ageing and various cancer types. Loss or
down-regulation of the p97 adaptor FAF1 has been observed in various
human cancers




Family B (patients B-2 and B-3)




Fig. 6 Schematic representation of the SPRTN mutations identified in
SPARTAN syndrome patients. The patient from family A contains two
truncated alleles of SPRTN where the C-terminal part is missing (ΔC).
The patients from family B contain one allele similar to family A (ΔC),
and one full-length allele with a single missense mutation (Y117C) in the
putativemetalloprotease domain SprT. aa amino acid. Colour code:MIU-
domain motif interacting with ubiquitin, SprT-domain SprT-like zinc
metallopeptidase, SHP-box (Shp1, eye-closed, p47), PIP-box PCNA
interacting peptide, UBZ-domain ubiquitin-binding zinc finger. Please
note that the parents and siblings of index patients bearing one SPRTN
wild-type allele together with one mutated allele WT/ Y117C or WT/ΔC
are unaffected individuals (not shown)
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hepatocellular carcinoma complications. The third patient
(B-3) was cured by liver transplantation and is currently stable
and in good health 2 years post-operation (David Amor and
Paul Lockhart, personal communication).
The C-terminal region of SPRTN contains the p97-
interacting motif (SHP), PCNA interacting box (PIP) and
ubiquitin-binding domain (UBZ domain). Therefore, the
pathogenicity of the SPRTN-ΔC mutation found in the
A-1 patient could easily be explained by its inability to
be recruited to the sites of stalled and collapsed DNA rep-
lication forks, due to its missing PIP-box, and an inability
to recruit p97, due to its missing SHP-domain, to segregate
substrates at the fork. Interestingly, the two patients from
family B (B-2 and B-3) have a similar mutation to patient
A-1 on one allele, SPRTN-ΔC; however, on the other al-
lele, they only have a single amino acid change (Y117C) in
SprT-domain, a putative metalloprotease domain (Fig. 6).
As the parents and healthy siblings of the affected patients
contain one SPRTN wild-type allele and one mutated allele,
and do not develop any signs of this syndrome, we con-
cluded that the missense mutation in SprT domain must be
pathogenic in order for patients B1 and B2 to develop the
disease, and that this domain has an essential role in ge-
nome stability and cancer protection in humans. Molecular
analysis of SPRTN and disease-related mutations has re-
vealed that SPRTN plays an essential role in DNA replica-
tion fork progression and stability, as well as in guarding
G2/M checkpoint function (Lessel et al. 2014).
These results suggest that the putative metalloprotease do-
main of SPRTN plays an essential role in DNA replication and
the prevention of genome instability in humans. This raises
the question as to why a single missense mutation in the SprT
domain is pathogenic and whether the SprT domain indeed
possesses essential metalloprotease activity.
Similarly to SPRTN-mutated patients, haploinsufficiency
of SPRTN in mice causes chromosomal instability, cellular
senescence and progeroid phenotypes characterised by cata-
racts, lodrokyphosis and cachexia at a young age (Maskey
et al. 2014). However, complete loss of SPRTN (−/−) causes
early embryonic lethality (before embryonic day 7).
In both human andmouse studies, it has been demonstrated
that the putative metalloprotease SprT-domain of SPRTN
plays an essential role in DNA replication and cell prolifera-
tion (Lessel et al. 2014; Maskey et al. 2014). Interestingly, a
SPRTN-like protein in yeast, WSS1, was recently shown to
function as a DNA-dependent metalloprotease, which in com-
bination with p97/Cdc48, cleaves Top1-cc (Stingele et al.
2014). Thus, a further in-depth biochemical investigation of
SPRTN, and its potential protease activity, is required to sup-
port our hypothesis that human SPRTN is also a
metalloprotease essential for the removal of Top1-cc or even
other and not yet identified DPCs in front of the DNA repli-
cation fork.
FAF1-mutated/low expressed cancers In addition to SPRTN
mutations, it was recently demonstrated that mutations or low
expression levels of FAF1, another p97 cofactor, are associat-
ed with several cancer types (Liu et al. 2012; Menges et al.
2009; Weber 2015). FAF1 is essential for the stability of DNA
replication forks in worms and human cell lines (Franz et al.
2016). Therefore, the role of FAF1 in carcinogenesis could be
directly linked to the function of FAF1 in DNA replication.
The p97-FAF1 complex (CDC-48-UBXN-3) binds and facilitates
the proteasome-dependent degradation of the licensing factor
CDT-1/Cdt1 and the components of the main DNA replication
helicase CMG (Cdc45 and GINS) and thus allowing proper
DNA synthesis. Elevated levels of Cdt1 and CMG helicase
were shown to cause DNA replication stress manifested by re-
replication and severe genomic instability that could lead to
cancer (Karavias et al. 2016; Seo et al. 2005; Srinivasan et al.
2013). Moreover, it was also suggested that the ubiquitin-
binding domain of FAF1 is essential for its function in protec-
tion from carcinogenesis (Lee et al. 2012). Therefore, the main
role of FAF1 in protection from carcinogenesis could be its
function in DNA replication. Hence, it would be worthwhile
checking whether FAF1-mutated/low expressed cancers con-
tain elevated level of Cdt1, Cdc45 and GINS.
Werner syndrome The role of the p97 system in ageing and
cancer is further emphasised by the role of p97 in Werner
protein (WRN) mobility after DNA replication stress (Indig
et al. 2004; Partridge et al. 2003). Mutations in Werner gene/
protein cause Werner syndrome (WS), one of best
characterised human premature ageing syndromes resembling
physiological ageing at an early age (Coppede 2012). In con-
trast to usual ageing, WS is characterised by multiple cancers,
and these include disproportional number of sarcomas, affect-
ing middle-aged patients (Friedrich et al. 2010). WS is an
autosomal recessive genetic disease caused by mutations in
WRN. WRN is a member of the RecQ DNA helicase family
and has 3′-5′ DNA helicase and 3′-5′ exonuclease activities
(Rossi et al. 2010). WRN has multifunctional roles in the
maintenance of genome stability, including its role in DNA
replication, DNA repair and RNA transcription. The role of
WRN in DNA replication is not completely clear. However,
WRN physically associates with components of the DNA rep-
lication fork as it interacts with replicative and TLS DNA
polymerases δ and η and RPA (Hyun et al. 2012; Kamath-
Loeb et al. 2000, 2007). It was also shown that WRN in-
creases DNA pol δ processivity as well as its localisation in
the nucleolus. It has been suggested that WRN helicase activ-
ity resolves difficult DNA structures such as G-quadruplex
and Holliday junctions in front of the DNA replication fork,
and that the 3′-5′ exonuclease activity of WRN degrades al-
ternative DNA structures and assists DNA polymerase δ in
high fidelity DNA synthesis (Kamath-Loeb et al. 2012)
(Croteau et al. 2014). p97 physically interacts with WRN in
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nucleoli (Partridge et al. 2003). This interaction is direct and
carried out via the conserved RecQ domain of WRN (Indig
et al. 2004). The p97-WRN complex is disrupted by a Top1
inhibitor camptothecin and WRN is released from nucleoli.
The molecular mechanism of the p97-WRN interaction is
not yet clear, but the aforementioned results suggest that p97
regulates WRN release from nucleoli during DNA replication
stress, and thus, p97 might facilitate WRN recruitment to sites
of stalled and/or collapsed DNA replication fork. The role of
p97 in WRN dynamics is an additional example of how the
disturbance of the p97 system related to processes involved in
DNA replication might directly cause premature ageing and
cancer.
Concluding Remarks
This review article aims to emphasise the essential role of the
ubiquitin-dependent molecular segregase p97 (VCP or
Cdc48) in DNA replication. Here, we present a body of evi-
dence that suggests a central role for p97 and its cofactors (p97
system) in DNA replication. There is more and more evidence
that DNA replication stress is one of the main causes of var-
ious types of cancer, both sporadic and hereditary, but also
tissue degeneration and ageing (Khurana and Oberdoerffer
2015; Lessel et al. 2014; Macheret and Halazonetis 2015).
Hence, we feel that generating new knowledge and awareness
of every aspect of DNA replication is essential for biology and
medicine. From the aforementioned facts, it is clear that mo-
lecular insights into p97 during DNA replication are essential,
and most probably tightly coupled with the proteasome deg-
radation machinery. It is highly probable that p97 regulates
many other not yet discovered substrates throughout the
DNA replication processes. Understanding the role of p97 in
DNA replication is therefore paramount for our understanding
of ageing-related diseases, cancerogenesis and cancer therapy.
Disturbance of the p97 system, such as by mutations in
SPRTN or FAF1, severely affect the progression of the DNA
replication fork and causes DNA replication stress in prolifer-
ating cells. Altogether, we conclude that p97, along with its
cofactors Ufd1, Npl4, SPRTN, WSS1 and FAF1/UBXN-3,
plays a strategic and conserved role in DNA replication from
yeast to humans. Accordingly, molecular insights into p97, its
cofactors and substrates during DNA replication are essential
to our understanding of genome stability. As the components
of the ubiquitin-proteasome system and DNA replication have
already been used for the treatment of various malignancies,
the function of the p97 system in DNA replication accentuates
additional complexities, but also gives excellent diagnostic
and therapeutic opportunities for ageing-related diseases such
as cancer and tissue degeneration. The role of p97 in DNA
replication should be especially considered for cancer therapy
and for therapeutics that directly affect DNA replication, such
as topoisomerase 1 and 2 inhibitors (Chazin Ede et al. 2014;
Chen et al. 2015; Pommier 2013). Topoisomerase inhibitors
trap the topoisomerase 1 and 2 cleavage complex on DNA,
consequently blocking the progression of DNA replication
and transcription, thus inhibiting cell proliferation (Ashour
et al. 2015). As p97/Cdc48-complexes in yeast (Stingele
et al. 2014) are able to remove toxic topoisomerase cleav-
age complexes from DNA (Stingele et al. 2015), cancer
cells with elevated level of p97 (Yamamoto et al. 2003a,
b, 2004a, b, 2005) might be completely resistant to topo-
isomerase inhibitors; whether this mechanism is also rele-
vant in mammalian cells needs to be further addressed. In
addition, a proteasome inhibitor bortezomib (Velcade®) is
used for the treatment of B cell malignancies such as
mantle cell lymphoma and myeloma (Robak et al. 2015).
However, the mechanistic insight of how bortezomib in-
hibits cancer cell growth and killing remains unclear
(McCormack 2015). The ATPase activity of p97 remodels
and segregates many ubiquitinated substrates in tight coor-
dination with the proteasome (Barthelme et al. 2014,
2015; Sha and Goldberg 2014). Therefore, inhibiting
proteasomal activity could also have an effect on p97
function in DNA replication. p97 is a new and potential
target for cancer therapy, and the development of p97
inhibitors has recently generated a lot of attention
(Chapman et al. 2015a, b; Chou et al. 2011; Deshaies
2014; Magnaghi et al. 2013). Furthermore, there are cur-
rently several p97 inhibitors in clinical trials for cancer
therapy (http://www.cleavebio.com/pipeline/p97.aspx). For
that reason, the understanding of the precise molecular
mechanism of p97 and its substrates during DNA
replication will be of a direct benefit for cancer therapy.
We believe that this review highlights the role of p97
in genome stability, cancer and ageing and establishes
the p97-system as an integral part of the DNA replica-
tion machinery.
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